Elliot S Howard

US Patent:

20210161661, Jun 3, 2021

Filed:

Feb 11, 2021

Appl. No.:

17/173430

Inventors:

- Santa Rosa CA, US
Grainne Teresa Carroll - Galway, IE
Paul Devereux - Galway, IE
Niall Duffy - Galway, IE
Matthew Fleming - Roscommon, IE
Alexander J. Hill - Blaine MN, US
Elliot J. Howard - Redwood City CA, US
James R. Keogh - Maplewood MN, US
Marian Patricia Lally - Galway, IE
Luke Lehmann - Newport Beach CA, US
Jeffrey Madden - Galway, IE
Kevin M. Mauch - Windsor CA, US
Ciaran McGuinness - Roscommon, IE
Brian T. McHenry - Golden Valley MN, US
Karl L. Olney - Tustin CA, US
Geoffrey Orth - Sebastopol CA, US
Edward Sarnowski - Newport Coast CA, US
Elizabeth A. Schotzko - Blaine MN, US
Benjamin Wong - Irvine CA, US

Assignee:

Medtronic Vascular, Inc. - Santa Rosa CA

International Classification:

A61F 2/24

Abstract:

Methods of transcatheter delivery of a prosthetic heart valve. A distal region of a guide member assembly is advanced into a heart of a patient. The distal region is docked to native anatomy of the heart. A delivery device, including a collapsed prosthetic heart valve, is advanced over the docked guide member assembly. The collapsed prosthetic heart valve is located at an implantation site. The prosthetic heart valve is deployed from the delivery device, and then the delivery device is removed from the patient. At least a portion of the guide member assembly is removed from the patient. In some embodiments, the docking structure is docked to one or more of native mitral valve leaflets, chordae in the left ventricle, or walls of the left ventricle as part of a transseptal mitral valve delivery procedure.

US Patent:

20200187945, Jun 18, 2020

Filed:

Dec 13, 2019

Appl. No.:

16/714611

Inventors:

- Irvine CA, US
Robert S. Schwartz - Inver Grove Heights MN, US
Glen Rabito - Lake Forest CA, US
Robert C. Taft - Orange CA, US
Elliot Howard - Irvine CA, US
Alexander Siegel - Aliso Viejo CA, US
Joseph Passman - Costa Mesa CA, US

Assignee:

NXT Biomedical - Irvine CA

International Classification:

A61B 17/11
A61B 5/145
A61B 5/00
A61B 17/00
A61B 17/12

Abstract:

Methods and devices for increasing oxygenation levels in the blood supply and thereby treating the condition of hypoxemia. Multiple approaches such as pressure reduction in the pulmonary circulatory system, reducing triggering mechanisms in the main pulmonary artery and restricting flow in the pulmonary circulatory system are disclosed. Interventions associated with those approaches can including shunting, restrictors, compliance devices, pharmacologic substances, etc.

US Patent:

20190254816, Aug 22, 2019

Filed:

Feb 22, 2019

Appl. No.:

16/282885

Inventors:

- Santa Rosa CA, US
Grainne Teresa Carroll - Galway, IE
Paul Devereux - Galway, IE
Niall Duffy - Galway, IE
Matthew Fleming - Roscommon, IE
Alexander J. Hill - Blaine MN, US
Elliot J. Howard - Redwood City CA, US
James R. Keogh - Maplewood MN, US
Marian Patricia Lally - Galway, IE
Luke Lehmann - Newport Beach CA, US
Jeffrey Madden - Galway, IE
Kevin M. Mauch - Windsor CA, US
Ciaran McGuinness - Roscommon, IE
Brian T. McHenry - Golden Valley MN, US
Karl L. Olney - Tustin CA, US
Geoffrey Orth - Sebastopol CA, US
Edward Sarnowski - Newport Coast CA, US
Elizabeth A. Schotzko - Blaine MN, US
Benjamin Wong - Irvine CA, US

Assignee:

Medtronic Vascular, Inc. - Santa Rosa CA

International Classification:

A61F 2/24

Abstract:

Methods of transcatheter delivery of a prosthetic heart valve. A distal region of a guide member assembly is advanced into a heart of a patient. The distal region is docked to native anatomy of the heart. A delivery device, including a collapsed prosthetic heart valve, is advanced over the docked guide member assembly. The collapsed prosthetic heart valve is located at an implantation site. The prosthetic heart valve is deployed from the delivery device, and then the delivery device is removed from the patient. At least a portion of the guide member assembly is removed from the patient. In some embodiments, the docking structure is docked to one or more of native mitral valve leaflets, chordae in the left ventricle, or walls of the left ventricle as part of a transseptal mitral valve delivery procedure.